M7

(redirected from AMegaL)
Also found in: Wikipedia.

FAB classification

French-American-British classification of acute leukemia Hematology A schema that divides acute leukemias into lymphoid–ALL or myeloid–AML cell lines; of childhood ALL, 70% are predominantly L1, 27% are L2, and 3% or less are L3 or Burkitt cell type, in adults with ALL, 30% are L1, 65% are L2, and 5% are L3
FAB classification, acute leukemias
Acute lymphocytic leukemia (ALL)
L1  Small monotonous lymphocytes
L2  Mixed L1- and L3-type lymphocytes
L3  Large homogeneous blast cells
Acute myeloid leukemia (AML)
M1  Myeloblasts without maturation
M2  Myeloblasts with maturation (best AML prognosis)
M3  Hypergranular promyelocytic leukemia (faggot cells)
M3V  Variant, microgranular promyelocytic leukemia
M4  Myelomonocytic leukocytes
M5  Monocytic, subtype
  a. Poorly differentiated monocytic leukemia
  b. Well differentiated monocytic leukemia
M6  Erythroleukemia/DiGuglielmo syndrome
M7  Megakaryocytic leukemia Pleomorphic undifferentiated cells with cytoplasmic blebs; myelofibrosis or ↑ BM reticulin; positive for platelet peroxidase antifactor VIII

M7

,

AMegaL

acute megakaryoblastic leukemia.